November 18, 2017 1:12 PM ET

Biotechnology

Company Overview of Neurimmune Holding AG

Company Overview

Neurimmune Holding AG, a biotechnology company, engages in the development and commercialization of human antibody therapeutics for the treatment and prevention of common human diseases. The company focuses on protein aggregation diseases; and neurodegenerative disorders, such as Alzheimer’s disease. Its pipeline comprises programs in neurodegeneration, including Alzheimer's and Parkinson's diseases, tauopathies, and amyotrophic lateral sclerosis or Lou Gehrig's disease. The company develops human monoclonal antibodies as therapeutics based on its Reverse Translational Medicine technology platform. Neurimmune Holding AG was founded in 2006 and is based in Schlieren, Switzerland.

Wagistrasse 13

Schlieren,  8952

Switzerland

Founded in 2006

Phone:

41 44 755 46 46

Fax:

41 44 755 46 47

Key Executives for Neurimmune Holding AG

Founder, President of The Board and President
Founder and Chief Scientific Officer
Chief Financial Officer
Chief Operating Officer and General Manager
Compensation as of Fiscal Year 2017.

Neurimmune Holding AG Key Developments

Neurimmune Holding AG Presents at Charles River World Congress on Animal Models in Drug Discovery & Development, Sep-26-2017 02:30 PM

Neurimmune Holding AG Presents at Charles River World Congress on Animal Models in Drug Discovery & Development, Sep-26-2017 02:30 PM. Venue: Sheraton Copley Place, Boston, Massachusetts, United States. Speakers: Jan Grimm, Founder and Chief Scientific Officer.

Neurimmune Holding AG Presents at 10th Annual International Partnering Conference BioPharm America, Sep-26-2017 01:30 PM

Neurimmune Holding AG Presents at 10th Annual International Partnering Conference BioPharm America, Sep-26-2017 01:30 PM. Venue: Sheraton Boston Hotel, Boston, Massachusetts, United States. Speakers: Jan Grimm, Founder and Chief Scientific Officer.

Similar Private Companies By Industry

Company Name Region
4bases S.A. Europe
AB2 Bio Ltd. Europe
ADC Products Switzerland SARL Europe
ADC Therapeutics SA Europe
AlloCyte Pharmaceuticals AG Europe

Recent Private Companies Transactions

Type
Date
Target
Private Placement
December 7, 2016
AL-S Pharma AG
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Neurimmune Holding AG, please visit www.neurimmune.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.